{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:36:18Z","timestamp":1649133378246},"reference-count":11,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.3960\/jslrt.18031","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T22:05:44Z","timestamp":1585346744000},"page":"26-28","source":"Crossref","is-referenced-by-count":1,"title":["Relapsed refractory nodal peripheral T-cell lymphoma with follicular                    helper T-cell phenotype was initially resistant to pralatrexate and confirmed to                    be unresponsive to subsequent forodesine, but responded to re-instituted                    pralatrexate"],"prefix":"10.3960","volume":"60","author":[{"given":"Yasunobu","family":"Sekiguchi","sequence":"first","affiliation":[{"name":"Department of                    Hematology, Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of                    Hematology, Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruko","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of                    Hematology, Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Iizuka","sequence":"additional","affiliation":[{"name":"Department of                    Hematology, Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakura","family":"Sakajiri","sequence":"additional","affiliation":[{"name":"Department of                    Hematology, Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of                    Hematology, Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadaaki","family":"Inano","sequence":"additional","affiliation":[{"name":"Department of Hematology,                        Juntendo University Hospital Bunkyo-ku,                        Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Hematology,                        Juntendo University Hospital Bunkyo-ku,                        Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Hamano","sequence":"additional","affiliation":[{"name":"Department of Hematology,                        Juntendo University Hospital Bunkyo-ku,                        Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Tomita","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Pathology,                    Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Izumi","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Pathology,                    Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Okubo","sequence":"additional","affiliation":[{"name":"Laboratory of Blood Transfusion, Urayasu-shi,                        Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Juntendo                    University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Juntendo                    University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Hematology,                        Juntendo University Hospital Bunkyo-ku,                        Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of                    Hematology, Urayasu-shi, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Vose J, Armitage J, Weisenburger D.                        International peripheral T-cell and natural killer\/T-cell                        lymphoma study: pathology findings and clinical outcomes.                    J Clin Oncol. 2008; 26:                        4124-4130.","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Park S, Ko YH.                        Peripheral T cell lymphoma in Asia.                    Int J Hematol. 2014; 99:                        227-239.","DOI":"10.1007\/s12185-014-1520-3"},{"key":"3","unstructured":"3 NCCN Clinical practice guidelines in                    oncology. T-cell lymphomas Version 3. 2018. http:\/\/WWW.nccn.org. Accessed 9 August 2018."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Ellin F, Landstr\u00f6m J, Jerkeman M, Relander T.                        Real-world data on prognostic factors and treatment in                        peripheral T-cell lymphomas: a study from the Swedish Lymphoma                        Registry.                    Blood. 2014; 124:                        1570-1577.","DOI":"10.1182\/blood-2014-04-573089"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Chihara D, Fanale MA, Miranda RN <i>et al.<\/i>                    The survival outcome of patients with relapsed\/refractory                        peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic                        T-cell lymphoma.                    Br J Haematol. 2017; 176:                        750-758.","DOI":"10.1111\/bjh.14477"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 O\u2019Connor OA, Pro B, Pinter-Brown L <i>et al.<\/i>                    Pralatrexate in patients with relapsed or refractory peripheral                        T-cell lymphoma: results from the pivotal PROPEL study.                    J Clin Oncol. 2011; 29:                        1182-1189.","DOI":"10.1200\/JCO.2010.29.9024"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K.                        Forodesine in the treatment of relapsed\/refractory peripheral                        T-cell lymphoma: an evidence-based review.                    OncoTargets Ther. 2018; 11:                        2287-2293.","DOI":"10.2147\/OTT.S140756"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Maruyama D, Tobinai K, Ogura M <i>et al.<\/i>                    Romidepsin in Japanese patients with relapsed or refractory                        peripheral T-cell lymphoma: a phase I\/II and pharmacokinetics                        study.                    Int J Hematol. 2017; 106:                        655-665.","DOI":"10.1007\/s12185-017-2286-1"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Ogura M, Ishida T, Hatake K <i>et al.<\/i>                    Multicenter phase II study of mogamulizumab (KW-0761), a                        defucosylated anti-cc chemokine receptor 4 antibody, in patients with                        relapsed peripheral T-cell lymphoma and cutaneous T-cell                        lymphoma.                    J Clin Oncol. 2014; 32:                        1157-1163.","DOI":"10.1200\/JCO.2013.52.0924"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Pro B, Advani R, Brice P <i>et al.<\/i>                    Five-year results of brentuximab vedotin in patients with                        relapsed or refractory systemic anaplastic large cell                        lymphoma.                    Blood. 2017; 130:                        2709-2717.","DOI":"10.1182\/blood-2017-05-780049"},{"key":"11","unstructured":"11 Oiwa K, Hosono N, Nishi R,                    O\u2019Connor O, Yamauchi T. Generation and Characterization of                    pralatrexate-resistant cell line. 10th Annual T-cell lymphoma                    forum."}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/1\/60_18031\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T04:02:04Z","timestamp":1585368124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/1\/60_18031\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.18031","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}